FUSED HETEROCYCLIC COMPOUND AND MEDICINAL USE THEREOF
申请人:Mitsubishi Pharma Corporation
公开号:EP1396488A1
公开(公告)日:2004-03-10
The fused heterocyclic compound of the present invention, which is represented by the formula (I):
wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.
[EN] BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS<br/>[FR] ANALOGUES DE LA BRYOSTATINE ET UTILISATION DE CEUX-CI EN TANT QU'AGENTS ANTIVIRAUX
申请人:UNIV UTAH RES FOUND
公开号:WO2016025363A1
公开(公告)日:2016-02-18
Described herein are tricyclic macrolactones. The macrolactones have a high binding affinity for PKC. The compounds described herein can be used in a number of therapeutic applications including the treatment or prevention of viral infection. Also described herein are methods for producing macrolactones. The methods permit the high-yield synthesis of macrolactones in a low number of steps and with a high degree of substitution and specificity.
COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B
申请人:Heyes James
公开号:US20130123339A1
公开(公告)日:2013-05-16
The present invention provides compositions and methods for the delivery of interfering RNAs such as siRNAs that silence APOB expression in cells such as liver cells. In particular, the nucleic acid-lipid particles provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells such as liver cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of APOB at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.
Improved detergent compositions, especially granular automatic dishwashing detergents, comprising multiquaternary bleach activators are provided. The bleach activators contain multiple quaternary nitrogen groups, preferably at least three such groups and preferably have at least one quaternary nitrogen group in the peracid-forming portion of the bleach activator as well as at least one quaternary nitrogen group in the leaving-group portion.
Fused heterocyclic compound and medicinal use thereof
申请人:——
公开号:US20040176361A1
公开(公告)日:2004-09-09
The fused heterocyclic compound of the present invention, which is represented by the formula (I):
1
wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.